Affinity Asset Advisors, LLC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1773195 NEW YORK, NY

Position in AMLX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,778,022

New position

Shares Held

98,999

first reported quarter

Ownership

0.089%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#83

of 207 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Affinity Asset Advisors, LLC holds $73,399,142 across 3 Drug Manufacturers - Specialty & Generic names. AMLX ranks #3 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	1,125,000	$58,950,000
2	TEVA	Teva Pharmaceutical Industries Ltd	374,000	$12,671,120
3	AMLX	Amylyx Pharmaceuticals, Inc. This page	98,999	$1,778,022

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,778,022	98,999	—	Shares	Sole	2026-08-13
No filing history on record for this holder in this stock.